Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03103477 · ClinicalTrials.gov registry record
Platelet Activating Factor Stability in Urine
A clinical trial, sponsored by St. Louis University.
- Completed
- Registry status
- 16
- Enrollment target
NCT03103477 is a clinical trial that has completed, run by St. Louis University. The registered enrollment target is 16 participants.
The verdict
NCT03103477 has completed, sponsored by St. Louis University.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
The investigator's hypothesis is that smoking induces inflammation in the bladder wall. This may predispose to the development of Interstitial cystitis(IC) / bladder pain syndrome(BPS). Previous research has linked one the Platelet Activating Factor - PAF to interstitial cystitis. The investigators will study a limited number of patients to determine whether PAF is stable in urine and whether special precautions (for example - immediate freezing in liquid nitrogen) is necessary for accurate measurement of PAF in the urine. Patients who are presenting for an office visit will be asked to donate at least 50 ml of urine. A separate group of patients who are scheduled for surgery, are also being asked to donate around 25 ml of urine during surgery. No patient data other than group assignment, whether they smoke or if they have or not have interstitial cystitis will be recorded.
Interventions
- OTHER Urine stability
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2017-01-27 |
| Est. Completion | 2017-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03103477
The ClinicalTrials.gov registry entry for NCT03103477 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Louis University, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Urine stability is the first listed.
NCT03103477 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03103477 about?
NCT03103477 is a clinical study titled "Platelet Activating Factor Stability in Urine". The investigator's hypothesis is that smoking induces inflammation in the bladder wall. This may predispose to the development of Interstitial cystitis(IC) / bladder pain syndrome(BPS). Previous research has linked one the Platelet Activating Factor - PAF to interstitial cystitis. The investigators ...
What is the current status of trial NCT03103477?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2017-01-27. Estimated completion is 2017-02-28.
What interventions are being tested in trial NCT03103477?
The interventions under investigation include: Urine stability (OTHER).
Who is sponsoring clinical trial NCT03103477?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.